Relationship between improvement of glycaemic control and reduction of major cardiovascular events in 15 cardiovascular outcome trials: A meta‐analysis with meta‐regression

Author:

Giugliano Dario1ORCID,Bellastella Giuseppe1,Longo Miriam1,Scappaticcio Lorenzo1,Maiorino Maria Ida2ORCID,Chiodini Paolo3,Esposito Katherine2

Affiliation:

1. Division of Endocrinology and Metabolic Diseases, Department of Advanced Medical and Surgical SciencesUniversità della Campania Luigi Vanvitelli Naples Italy

2. Diabetes Unit, Department of Advanced Medical and Surgical SciencesUniversità della Campania Luigi Vanvitelli Naples Italy

3. Medical Statistics UnitUniversità della Campania Luigi Vanvitelli Naples Italy

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference36 articles.

1. Food and Drug Administration. Guidance for industry: diabetes mellitus ‐ evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes. Silver Spring Maryland: Food and Drug Administration December 2008.www.fda.gov/downloads/Drugs/Guidances/ucm071627.pdf. Accessed March 24 2020.

2. Heart failure and type 2 diabetes: From cardiovascular outcome trials, with hope

3. Safety of SGLT2 Inhibitors in Patients with Diabetes Mellitus

4. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary

5. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2020

Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3